Prognostic value of neutrophil-to-lymphocyte ratio in advanced cancer patients receiving immunotherapy
D. Viñal, Laura Gutiérrez-Sainz, D. Martínez, J. A. Garcia-Cuesta, Javier Pérez Pedregosa, J. Villamayor, L. Ostios, Darío Sánchez-Cabrero, Oliver Higuera, Álvaro Pinto, Nuria Rodrı́guez-Salas, Enrique Espinosa, J. de Castro, Jaime Feliú
Topics & Concepts
MedicineInternal medicineNeutrophil to lymphocyte ratioImmunotherapyMultivariate analysisProgression-free survivalCancerOncologyLymphocyteOverall survivalGastroenterologyInflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and BiomarkersImmune cells in cancer